Vassilis Golfinopoulos

Vassilis Golfinopoulos

UNVERIFIED PROFILE

Are you Vassilis Golfinopoulos?   Register this Author

Register author
Vassilis Golfinopoulos

Vassilis Golfinopoulos

Publications by authors named "Vassilis Golfinopoulos"

Are you Vassilis Golfinopoulos?   Register this Author

34Publications

1149Reads

33Profile Views

EORTC SPECTA-AYA: A unique molecular profiling platform for adolescents and young adults with cancer in Europe.

Int J Cancer 2019 Aug 29. Epub 2019 Aug 29.

Division of Cancer Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32651DOI Listing
August 2019

Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study.

Neurology 2019 06 10;92(24):e2754-e2763. Epub 2019 May 10.

From the University Medical Center & German Cancer Research Center (M.N., F.S., I.H., P.K., M.P., M.B., W.W.), Heidelberg, Germany; EORTC Headquarters (T.G., V.G.), Brussels, Belgium; Brain Tumor Center at Erasmus MC Cancer Institute (J.E.C.B., W.T., M.J.v.d.B.), Rotterdam, the Netherlands; Medical Oncology Department (A.A.B.), AUSL-Bologna-IRCCS Scienze Neurologiche, Bologna, Italy; Haaglanden Medical Center (M.J.B.T.), the Hague; Leiden University Medical Center (M.J.B.T.), the Netherlands; Institut Gustave Roussy (J.D.), Villejuif; Sorbonne Université (A.I.), Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle Épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Service de Neurologie 2-Mazarin, Paris; Institut de Cancerologie de l'Ouest (ICO)-Centre Rene Gauducheau (M.C.), Saint-Herblain, France; Leuven Cancer Institute-KU Leuven (P.M.C.), Belgium; Department of Neurology and Brain Tumor Center (M.W.), University Hospital and University of Zurich, Switzerland; Institut Régional du Cancer Montpellier (M.F.); University of Lille (E.L.R.), U-1192, Inserm; CHU Lille (E.L.R.), General and Stereotaxic Neurosurgery Service; Oscar Lambret Center (E.L.R.), Neurology, Lille, France; Department of Neurology (M.P.), Medical Faculty Mannheim, Heidelberg University, Germany; and Department of Neurology (M.N.), Medical University Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000007643DOI Listing
June 2019

Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial.

Lancet Oncol 2018 09 13;19(9):1170-1179. Epub 2018 Aug 13.

The Brain and Spine Institute (ICM), Sorbonne Université, The National Institute of Health and Medical Research (INSERM), National Centre for Scientific Research (CNRS), Public Assistance-Paris Hospitals (AP-HP), Hôpital Pitié-Salpêtrière, Paris, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045183036
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(18)30362-0DOI Listing
September 2018

Lomustine and Bevacizumab in Progressive Glioblastoma.

N Engl J Med 2017 11;377(20):1954-1963

From the University Medical Center and German Cancer Research Center, Heidelberg, Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B., M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the Netherlands; the Medical Oncology Department, Azienda Unità Sanitaria Locale di Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.); Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Service de Neurologie 2-Mazarin, INSERM Unité 1127, Centre National de la Recherche Scientifique Unité Mixte de Recherche (UMR) 7225, Sorbonne Universités, University Pierre and Marie Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Épinière, Paris (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau, Saint-Herblain (M.C.), Institut Régional du Cancer Montpellier, Montpellier (M.F.), and Centre Hospitalier Régional Universitaire de Lille, Lille (E.L.R., F.D.) - all in France; and the Departments of Oncology and Neurology, University Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1707358DOI Listing
November 2017

Precision Medicine: From "Omics" to Economics towards Data-Driven Healthcare - Time for European Transformation.

Biomed Hub 2017 Nov-Dec;2(Suppl 1):212-221. Epub 2017 Nov 21.

European Organisation for Research and Treatment of Cancer, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000480117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945945PMC
November 2017

Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.

Neuro Oncol 2017 Aug;19(8):1119-1126

Tel-Aviv Sourasky Medical Center, Tel-Aviv University; European Organization for Research and Treatment of Cancer, Brussels (EORTC); National Institutes of Health (M.R.M.); University of Alabama at Birmingham; Princess Margaret Cancer Centre, University of Toronto; Lausanne University Hospital; NRG Oncology Statistics and Data Management Center; Odette Cancer Centre and Sunnybrook Health Sciences Centre, University of Toronto; Samsung Medical Center, Sungkyunkwan University School of Medicine; Edinburgh Cancer Centre; Mayo Clinic; Robert-Janker Clinic at the University of Bonn Medical Centre, and MAASTRO clinic, GROW School for Oncology, Maastricht University Medical Centre; Miami Cancer Institute; Erasmus University Hospital; Dana-Farber Cancer Institute and Harvard Medical School; University of Zurich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570239PMC
August 2017

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.

N Engl J Med 2017 03;376(11):1027-1037

From Odette Cancer Centre, Sunnybrook Health Sciences Centre (J.R.P., A.S.) and Princess Margaret Cancer Centre (N.L., W.P.M.), Toronto, the Canadian Cancer Trials Group, Queens University, Kingston, ON (C.J.O., C.W., K.D.), University of Calgary, Calgary, AB (J.G.C.), University of Alberta, Edmonton (W.R.), Quality of Life Consulting, West Vancouver, BC (D.O.), Queen's University, Kingston General Hospital, Kingston, ON (J.P.R.), and Juravinski Cancer Centre, Hamilton, ON (H.H.) - all in Canada; Azienda Unità Sanitaria Locale- Istituto di Ricovero e Cura a Carattere Scientifico Istituto delle Scienze Neurologiche, Bologna (A.A.B., E.F.), and Fondazione Istituto Neurologico Carlo Besta, Milan (L. Fariselli) - both in Italy; University Hospital Gasthuisberg, Leuven, Belgium (J.M.); Peter MacCallum Cancer Centre, Melbourne, VIC (C.P.), University of Newcastle, Newcastle, NSW (M.F.), University of Queensland, Brisbane (M.F.), and Royal North Shore Hospital, Sydney (M.B.) - all in Australia; Saitama Medical University International Medical Center, Saitama, Japan (R.N.); Hôpital de la Pitié-Salpêtrière (F.L.-D., L. Feuvret), Paris, and Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Centre Hospitalier Universitaire Timone, Marseilles (O.C.) - both in France; the European Organization for Research and Treatment of Cancer, Brussels (V.G.); the Neurology Clinic, University of Heidelberg, Heidelberg, Germany (A.W., W.W.); Tauranga Hospital, Tauranga, New Zealand (M.T.); and Maastricht University Medical Center and School for Oncology and Developmental Biology, Maastricht, the Netherlands (B.G.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1611977DOI Listing
March 2017

Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Lancet Oncol 2016 Nov 27;17(11):1533-1542. Epub 2016 Sep 27.

Department of Medical Oncology and Cancer Centre, University Hospital Zurich, Zurich, Switzerland; Department of Radiation-Oncology (MAASTRO), Maastricht University Medical Centre (MUMC) and GROW (School for Oncology), Maastricht, Netherlands; Department of Radiation-Oncology, MediClin Robert-Janker-Clinic, Clinical Cooperation Unit Neuro-oncology, University Bonn Medical Centre, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30305-9DOI Listing
November 2016

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

N Engl J Med 2016 Aug;375(8):717-29

From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1602253DOI Listing
August 2016

European perspective for effective cancer drug development.

Nat Rev Clin Oncol 2014 08 17;11(8):492-8. Epub 2014 Jun 17.

UniversitaetsSpital Zurich, Division of Oncology, Raemistrasse 100, 8091 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2014.98DOI Listing
August 2014

Evaluating novel agent effects in multiple-treatments meta-regression.

Stat Med 2010 Oct;29(23):2369-83

Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.4001DOI Listing
October 2010

Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis.

Cancer Treat Rev 2009 Nov 17;35(7):570-3. Epub 2009 Jun 17.

Department of Medical Oncology/Digestive Oncology, Jules-Bordet Institute, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S030573720900087
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2009.05.005DOI Listing
November 2009

Adjuvant trials design in colon cancer.

Curr Opin Oncol 2009 Jul;21(4):367-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e32832cae48DOI Listing
July 2009

Donor-derived breast cancer in a bone marrow transplantation recipient.

Breast Cancer Res Treat 2009 Jan 9;113(2):211-3. Epub 2008 Feb 9.

Department of Medical Oncology, Ioannina University Hospital, Niarchou Avenue, 45500, Ioannina, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-008-9922-7DOI Listing
January 2009

Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis.

Lancet Oncol 2007 Oct 20;8(10):898-911. Epub 2007 Sep 20.

Division of Medical Oncology, University of Ioannina School of Medicine, Ioannina, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(07)70281-4DOI Listing
October 2007

Colorectal cancer screening coverage in Greece. PACMeR 02.01 study collaboration.

Int J Colorectal Dis 2007 May 29;22(5):475-81. Epub 2006 Aug 29.

Panhellenic Association for Continual Medical Research, Sections of Oncology and Public Health, 28 Karolou Street, Athens 10438, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00384-006-0186-6DOI Listing
May 2007

Colorectal cancer screening awareness among physicians in Greece.

BMC Gastroenterol 2006 Jun 6;6:18. Epub 2006 Jun 6.

Panhellenic Association for Continual Medical Research (PACMeR) Sections of Public-Health, 28, Karolou st, 10438 Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-230X-6-18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513238PMC
June 2006

"Juvenile" oncology--a missing subspecialty. The experience of a reference cancer centre.

Clin Transl Oncol 2006 Jun;8(6):444-9

Department of Medical Oncology, Ioannina University Hospital, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12094-006-0199-1DOI Listing
June 2006

Treatment of colorectal cancer in the elderly: a review of the literature.

Cancer Treat Rev 2006 Feb 5;32(1):1-8. Epub 2005 Dec 5.

School of Medicine, Department of Medical Oncology, University Hospital of Ioannina, GR-45110 Ioannina, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2005.10.002DOI Listing
February 2006